SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ:EXEL) announced today that Gisela Schwab, M.D., the company’s executive vice president and chief medical officer, will present at the Canaccord Genuity Growth Conference at 3:30 p.m. EDT / 12:30 p.m. PDT on Wednesday, August 10, 2011, in Boston. During the presentation, Dr. Schwab will review the most recent publicly available data for cabozantinib in castration-resistant prostate cancer (CRPC) and discuss the pivotal trial plans and regulatory strategy for the compound in CRPC. She will also discuss the company’s 2011 financial outlook and provide a general business update.
